At 25, your cells hold an abundant reserve of a discreet but foundational molecule: nicotinamide adenine dinucleotide, or NAD+. This coenzyme orchestrates energy production, activates DNA repair enzymes, and regulates the cellular stress response. By 50, those reserves have fallen by half. By 60, the decline is steeper still.
This is not a minor metabolic footnote. It is the signature of a silent energy crisis at the core of every cell.
NAD+: far more than a coenzyme
NAD+ is present in every living cell. Its best-known function is electron transfer in the mitochondrial respiratory chain — the process that converts nutrients into ATP, the universal energy currency. But reducing NAD+ to that single role misses the point.
This molecule is also the essential substrate for two families of enzymes critical to cellular longevity. On one side, sirtuins (SIRT1 through SIRT7): deacetylases (enzymes that modify other proteins by removing a chemical tag called an acetyl group, thereby changing their activity) that regulate gene expression, DNA repair, and mitochondrial biogenesis (the creation of new mitochondria, the cell's energy-producing organelles). On the other, PARPs (poly-ADP-ribose polymerases): DNA repair enzymes that consume NAD+ heavily whenever genotoxic damage (direct assaults on genetic material) occurs. Every time a DNA strand breaks under the pressure of free radicals or UV radiation, PARPs activate and draw down the NAD+ pool.
This dual role creates a biological tension. The more cellular stress accumulates (and stress accumulates with age), the more NAD+ is consumed. Less remains to fuel the mitochondria and sustain sirtuin activity.
Why NAD+ levels collapse with age
Research has identified several mechanisms converging toward this decline (PubMed).
The first is increased activity of CD38, an enzyme that degrades NAD+ and its precursors, including NMN (nicotinamide mononucleotide). Data published in Cell Metabolism show that CD38 expression rises significantly with age across multiple tissues (liver, skeletal muscle, adipose tissue) in both mice and humans. CD38 is now considered one of the primary drivers of age-related NAD+ depletion (PubMed).
The second mechanism is overconsumption by PARPs. Aging brings a progressive accumulation of DNA damage, which chronically activates PARPs. This sustained activation depletes NAD+ faster than it can be replenished.
The third factor is reduced activity of NAMPT (nicotinamide phosphoribosyltransferase), the key enzyme in the NAD+ recycling pathway. NAMPT converts nicotinamide (a breakdown product of NAD+) back into fresh NAD+. Less NAMPT means less endogenous NAD+ production.
These three forces act simultaneously and in the same direction. The result: a once-abundant molecule becomes progressively rate-limiting.
Tissue biology studies estimate that intracellular NAD+ levels fall by approximately 50% between ages 40 and 60, depending on the tissue analyzed.
The central consequence: mitochondrial dysfunction
In 2013, a study published in Cell described precisely what happens when nuclear NAD+ drops. Researchers observed that without NAD+, SIRT1 can no longer deactivate HIF-1α, a regulatory protein normally switched on only when oxygen is scarce. HIF-1α then accumulates in cells even under normal oxygen conditions, creating what the authors termed a pseudo-hypoxic state (the cell behaves as if it were starved of oxygen, even though it is not) (PubMed).
This pseudo-hypoxic state disrupts communication between the cell nucleus and the mitochondria. Nuclear and mitochondrial genes, which must be co-expressed in a coordinated fashion to properly assemble the respiratory chain (the sequence of reactions that produces cellular energy), fall out of sync. Electron transport chain complexes degrade. ATP production declines. Free radicals increase.
This is not simply a loss of efficiency. It is a vicious cycle: less NAD+ leads to more oxidative stress, which causes more DNA damage, which activates more PARPs, which consume yet more NAD+.
Sirtuins: guardians without fuel
Sirtuins deserve particular attention. These seven proteins (SIRT1 through SIRT7) collectively regulate hundreds of cellular processes: DNA repair, mitochondrial biogenesis, inflammation, glucose and lipid metabolism, stress resistance. SIRT1 and SIRT6 play roles in genomic stability. SIRT3, located in the mitochondria, regulates the activity of respiratory chain complexes.
Their shared characteristic: all are dependent on NAD+ as a cofactor. Without NAD+, they do not function.
The review published in Trends in Cell Biology by Imai and Guarente states this relationship plainly: the decline of NAD+ with age represents a metabolic "Achilles' heel," causing defects in nuclear and mitochondrial functions associated with many age-related pathologies (PubMed).
Reactivating sirtuins without restoring NAD+ is impossible. That is the central equation of cellular aging biology.
NMN and NR: the promise of precursors
Faced with this picture, research has turned to NAD+ precursors. Two molecules can raise NAD+ levels through oral supplementation: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). These two bioactives use slightly different metabolic pathways to convert into NAD+.
Human data are beginning to accumulate. A randomized controlled trial published in Cell Reports showed that NR supplementation (1 g/day for 21 days) in older men significantly increased NAD+ levels and its derivatives in skeletal muscle and reduced circulating inflammatory markers (PubMed). However, that same study found no improvement in mitochondrial biogenesis or systemic metabolism, highlighting the gap between biochemical NAD+ restoration and measurable functional effects.
More recently, a clinical trial published in the Journal of Gerontology demonstrated that MIB-626, a specific NMN formulation, increases blood NAD+ levels in a dose-dependent manner in adults aged 55 to 80 (PubMed). The increase is real and reproducible. But the authors explicitly note that long-term efficacy studies on clinical endpoints (physical capacity, cognition, metabolic markers) remain to be conducted.
That is where the honest frontier of current science lies: precursors work at the biochemical level. Their translation into tangible functional benefits requires longer trials, larger populations, and harder endpoints.
Within the bioactive taxonomy, NAD+ precursors (NMN and NR) belong to the geroprotector category: molecules that the body no longer produces in sufficient quantity with age and that target the fundamental mechanisms of cellular aging. They differ from essential nutrients (vitamins, minerals) in their mode of action. Essentials compensate for increased nutritional needs linked to the modern lifestyle. Geroprotectors such as NMN, taurine, and alpha-ketoglutarate target the biological pathways of aging directly.
Certain physical interventions also act on NAD+ metabolism. Finnish dry sauna (80-100 °C, 4 to 7 times per week) activates heat shock proteins (protective proteins the body produces in response to heat) and improves mitochondrial function through hormetic stress (a moderate stress that stimulates cellular defences) (PubMed). Hyperbaric oxygen therapy (60 sessions, 100% O2 at 2 atmospheres) produced in preliminary studies a 2.6% increase in telomere length (telomeres are protective caps at the ends of chromosomes that shorten with age) and a reduction of hs-CRP (a blood marker of chronic inflammation) to undetectable levels (PubMed). These interventions do not act on NAD+ through the same pathway as oral precursors. They modulate the cellular environment (oxidative stress, inflammation, mitochondrial biogenesis) in which NAD+ operates.
Measuring before acting
The practical question that follows is this: should everyone over 40 supplement with NMN or NR systematically? Not necessarily. And certainly not without knowing one's biological starting point.
NAD+ itself is not directly measurable through standard clinical testing. However, several biomarkers allow assessment of cellular and mitochondrial energy status, as well as oxidative stress levels — which consume NAD+. The profile of these markers provides an indirect but informative picture of the pressure placed on NAD+ reserves.
The biology of NAD+ illustrates a core principle of precision nutrition: the molecular mechanisms of aging are being progressively mapped, the tools to modulate them are beginning to emerge, but their relevance depends entirely on each individual's biological profile. Supplementing blindly, even with well-documented molecules, remains an approximation.
This is where the concept of a biological feedback loop becomes essential. A formula is never final. Your needs for NAD+ and geroprotectors shift with the season, stress levels, age, and physical activity. What worked six months ago may no longer match your current biology. Longevity science moves fast: the recent reassessment of resveratrol (long considered a sirtuin activator) is a telling example. A static protocol quickly becomes obsolete. Only regular monitoring of the relevant markers enables adjustments with the required precision.
The next generation of clinical trials will need to answer a more precise question: in which subpopulation, at which baseline NAD+ level, and at which calibration, do precursors produce clinically significant effects? Those are the data that will bridge convincing biochemistry and genuine precision medicine.
Frequently asked questions
References
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471 (PubMed).
- Gomes AP, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624-1638 (PubMed).
- Camacho-Pereira J, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab. 2016;23(6):1127-1139 (PubMed).
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141 (PubMed).
- Elhassan YS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. 2019;28(7):1717-1728 (PubMed).
- Pencina KM, et al. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults. J Gerontol A Biol Sci Med Sci. 2023;78(1):90-96 (PubMed).
- Laukkanen T, Khan H, Zaccardi F, Laukkanen JA. Association Between Sauna Bathing and Fatal Cardiovascular and All-Cause Mortality Events. JAMA Intern Med. 2015;175(4):542-548 (PubMed).
- Hadanny A, Efrati S. The Hyperoxic-Hypoxic Paradox. Biomolecules. 2020;10(6):958 (PubMed).
